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Tetherin (BST2/CD317) restricts the release of enve-
loped viral particles from infected cells. Coupled to
this virion retention, hominid tetherins induce proin-
flammatory gene expression via activating NF-kB.
We investigated the events initiating this tetherin-
induced signaling and show that physical retention
of retroviral particles induces the phosphorylation of
conserved tyrosine residues in the cytoplasmic tails
of tetherin dimers. This phosphorylation induces the
recruitment of spleen tyrosine kinase (Syk), which is
required for downstreamNF-kBactivation, indicating
that the tetherin cytoplasmic tail resembles the hemi-
immunoreceptor tyrosine-based activation motifs
(hemITAMs) found in C-type lectin pattern recogni-
tion receptors. Retroviral-induced tetherin signaling
is coupled to the cortical actin cytoskeleton via the
Rac-GAP-containing protein RICH2 (ARHGAP44),
and a naturally occurring tetherin polymorphism
with reduced RICH2 binding exhibits decreased
phosphorylation and NF-kB activation. Thus, upon
virion retention, this linkage to the actin cytoskeleton
likely triggers tetherin phosphorylation and subse-
quent signal transduction to induce an antiviral state.
INTRODUCTION
Tetherin (bonemarrow stromal cell antigen 2 [BST2] or CD317) is
an interferon-induced membrane protein that inhibits the release
of diverse enveloped viral particles from infected cells (reviewed
in Neil, 2013). Topologically, tetherin consists of a short N-termi-
nal cytoplasmic tail (CT), a transmembrane (TM) domain, an
extracellular rod-like coiled coil, and a C-terminal GPI anchor.
Parallel tetherin dimers partition into budding virions such that
after membrane scission, the GPI anchors of tetherin are pre-
dominantly retained in the viral membrane (Perez-Caballero
et al., 2009; Venkatesh and Bieniasz, 2013). Retained virions
can be endocytosed and targeted for endosomal degradation
(Neil et al., 2006; Neil et al., 2008). There are now several exam-
ples of virally encoded countermeasures that target tetherin.
These include the accessory proteins Nef and Vpu of primate
and human lentiviruses, respectively, which target the tetherinCell Host & Morthologs of their host species (Neil, 2013), and numerous lines
of evidence indicate that this function is maintained and selected
for throughout infection and upon cross-species transmission
(Go¨tz et al., 2012; Pickering et al., 2014; Sauter et al., 2012;
Serra-Moreno et al., 2011). It is likely that the adaptation of
Vpu to target human tetherin was a key event in the spread of
HIV-1 group M to become the predominant agent of the HIV/
AIDS pandemic (Sauter et al., 2009).
Alongside the strong genetic evidence that tetherin targets
primate lentiviruses in vivo, studies in mice indicate that tetherin
modulates retroviral pathogenesis (Barrett et al., 2012; Liberatore
and Bieniasz, 2011). Physical restriction of virion release also
has further associated antiviral effects. Recent studies have
shown that CD4+ T cells infected with HIV-1 mutants lacking
Vpu are more sensitive to antibody-dependent cellular cytoxicity
(ADCC) (Arias et al., 2014; Veillette et al., 2014). This is in part
due to enhanced opsonization of tetherin-retained virions by an-
tibodies targeting the viral envelope glycoprotein. Additionally,
we and others have shown that human tetherin is a potent acti-
vator of NF-kBwhen it restricts the release of retroviral and filovi-
ral particles (Cocka and Bates, 2012; Gala˜o et al., 2012; Tokarev
et al., 2013). This is determined by the recruitment of the E3 ubiq-
uitin ligases TRAF2 and TRAF6 that mediate the activation of the
kinase TAK1 (Gala˜o et al., 2012; Tokarev et al., 2013). In keeping
with this, there is an increase in the secretion of proinflammatory
cytokines from primary human CD4+ T cells infected with Vpu-
defective HIV-1 that is tetherin dependent (Gala˜o et al., 2012).
Theseobservations suggest that the coupling of proinflammatory
signaling to tetherin’s antiviral activity allows it to act as a sensor
of viral assembly, making the infected cell more visible to sys-
temic innate and adaptive immunity.
Mechanistically, tetherin-mediated signal transduction re-
quires both the structural attributes essential for restriction and
sequences in the CT (Gala˜o et al., 2012; Tokarev et al., 2013).
Among these is a dual-tyrosine-based motif (YDYCRV), previ-
ously shown to act as an endocytic sorting signal (Rollason
et al., 2007), that promotes the recycling of tetherin to and
from the cell surface. In the absence of this sequence, the
TRAF/TAK1 complex does not interact with tetherin (Gala˜o
et al., 2012; Tokarev et al., 2013). However, blockade of virion
endocytosis from the surface potentiates rather than abolishes
signaling, suggesting tetherin clustering in assembling virions
as the primary trigger (Gala˜o et al., 2012). Although the tyrosine
residues are well conserved, the ability of mammalian tetherins
to signal in human cells is highly species specific. Amino acid
changes in the tetherin CT that occurred during hominoidicrobe 16, 291–303, September 10, 2014 ª2014 The Authors 291
Figure 1. Tyrosine Phosphorylation of Transiently Expressed Human Tetherin
(A) Schematic representation of tetherin including the amino acid sequence of the cytoplasmic tail from human tetherin, with the conserved tyrosines highlighted
in gray.
(B) Fold activation of a firefly luciferase NF-kB reporter in 293 cells transiently transfected with tetherin, and mutants thereof, compared to control YFP vector
(top). Tetherin expression levels were confirmed by western blot (bottom).
(C) Lysates of 293 cells transiently expressing tetherin or the indicated mutant were immunoprecipitated with an anti-pY antibody. Deglycosylated precipitates
were analyzed by western blot using an anti-tetherin antibody.
(D) As in (C), but lysates were immunoprecipitated with an anti-tetherin antibody and blotted with an anti-pY antibody.
(E) Fold activation of NF-kB reporter in 293 cells transiently transfected with fixed amounts of NF-kB-luc reporter and wild-type tetherin plus increasing amounts
of tetherin tyrosine mutants (or wild-type as internal control). Total DNA amounts transfected were kept constant by the addition of pCR3.1 YFP. Fold changes
relative to YFP control.
(F) Lysates from (E) were immunoprecipitated with anti-pY and visualized by western blot. All error bars are ± SEM of three independent experiments. See also
Figure S1.
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A Syk-Dependent HemITAM in Tetherinevolution, culminating in a 5 amino acid deletion after divergence
from chimpanzees, account for the potency of human tetherin
signaling (Gala˜o et al., 2012). Tetherin is also expressed as
two isoforms in primary cells (Cocka and Bates, 2012). The
shorter of these lacks the tyrosine motif and dominantly inhibits
signaling, implying that only homodimers of the long isoform can
activate NF-kB. In this study we further characterized the role of
this motif in tetherin-mediated signal transduction.292 Cell Host & Microbe 16, 291–303, September 10, 2014 ª2014 ThRESULTS
Human Tetherin Is Phosphorylated on Conserved
Tyrosines in the CT upon Virion Retention
We have previously shown that human tetherin’s signaling is
dependent on a tyrosine motif (YDYCRV) (Figure 1A) (Gala˜o
et al., 2012; Rollason et al., 2007). Peptides corresponding to
the tetherin CT phosphorylated on either tyrosine have beene Authors
Cell Host & Microbe
A Syk-Dependent HemITAM in Tetherinfound in a phosphoproteome screen (St-Germain et al., 2009).
We hypothesized that the juxtaposition of two YDYCRV motifs
in a tetherin dimer may act as a noncanonical hemi-immunore-
ceptor tyrosine-based activation motif (hemITAM). Known hem-
ITAMs consist of single SH2-binding domains, YXX-hydrophobic
residue, in the CTs of several dimeric C-type lectins, which
recruit SH2-containing tyrosine kinases or phosphatases upon
phosphorylation (Suzuki-Inoue et al., 2006). Importantly, both
monomers of the dimer require intact tyrosine motifs to function.
Mutation of the Y6 to an alanine residue completely abolished
the activation of an NF-kB-dependent firefly luciferase reporter
gene upon transfection of human tetherin into 293 cells, whereas
a Y8A mutation affected the efficiency of signaling (Figure 1B).
Immunprecipitations (IPs) of cell lysates with anti-phosphotyro-
sine (anti-pY) antibody under these transfection conditions spe-
cifically pull down wild-type (WT) tetherin but not those bearing
tyrosine mutations (Figure 1C), indicating tetherin phosphoryla-
tion on one or both tyrosine residues. Consistent with this, paral-
lel IP of tetherin yielded a phosphotyrosine-specific band at the
size of deglycosylated WT tetherin only (Figure 1D), as did isola-
tion of WT but not Y6,8A mutant tetherin from cell lysates using
a phosphoprotein-specific resin (Figure S1A, available online).
Tetherin naturally exists as dimers of long and short isoforms,
and the short isoform acts as a dominant inhibitor of reporter
gene activation (Cocka andBates, 2012).We found that transient
transfection of tetherin Y6,8A in combination with WT at ratios of
2:1 or above completely inhibited tetherin-mediated reporter
gene activity (Figure 1E) and the concomitant ability to IP tetherin
with anti-pY antibodies (Figure 1F). In agreement with the re-
porter gene activities above, the single Y6A mutation also dis-
played this potent dominant-negative activity, whereas the Y8A
mutant was weaker (Figures 1E and S1B). Together these data
indicate that tetherin can be tyrosine phosphorylated and that
this correlates with NF-kB reporter activation. Furthermore, an
intact tyrosine motif must be present on both monomers of the
mature protein.
Tetherin expressed stably in cell lines does not constitutively
signal, but the restriction of viral particle release triggers NF-kB
reporter activation (Gala˜o et al., 2012). 293/tetherin cells were
transfected either with HIV-1 (WT) or HIV-1DVpu proviral clones
or with murine leukemia virus (MLV)-based vectors with or
without late-budding domain defects (Martin-Serrano et al.,
2004). As expected, infectious release of HIV-1DVpu and MLV
was reduced by between 10- and 30-fold in the presence of
tetherin and led to a 6- to 8-fold induction of the cotransfected
NF-kB reporter (Figures S2A and S2B). Consistent with this, IP
of the same cell lysates with anti-pY or passing the lysate
through a phosphoprotein column yielded evidence of tyro-
sine-phosphorylated tetherin (Figures 2A and 2B) triggered by vi-
rus budding. Mutation of the late-budding domain in MLV Gag
(MLVDPY) abolished tetherin phosphorylation, and restoration
of viral assembly by a heterologous late domain (MLVDPY/p6)
recovered it. 293 cells expressing single or double tyrosine point
mutations showed that Y6 was essential for both MLV- (Fig-
ure 2C) and HIVDVpu-induced NF-kB activity (Figure S2C). As
expected, none of the mutations had any effect on the ability
of tetherin to restrict virion release (Figures 2C and S2D). How-
ever, mutation of Y6 completely abolished the ability of both
MLV and HIVDVpu particles to promote isolation of phosphory-Cell Host & Mlated tetherin (Figures 2D, 2E and S2E). Interestingly, for virus
budding, mutation of Y8 appeared to reduce the efficiency of
phospho-tetherin isolation, in keeping with the reporter gene
activation data. Thus, phosphorylation of Y6 induced by virion
budding is essential for tetherin-mediated signal transduction,
and this is potentially stabilized by Y8. This facet is more easily
detected when tetherin signaling is activated by its physiological
ligand (viral particles) rather than by transient overexpression.
Finally, we tested tetherin mutants with signaling defects that
either do (tetherin RVP[10-12]AAA, which abolishes the last
two amino acids of the potential SH2-binding domain) or do
not (tetherin-3CA, which lacks the extracellular cysteine resi-
dues, or tetherin-DGPI) restrict virion release (Gala˜o et al.,
2012; Perez-Caballero et al., 2009) (Figures S2F and S2G). In
all cases, the ability of MLV assembly to induce tetherin phos-
phorylation was lost, indicating virion retention as a prerequisite.
In our previous study, restriction of HIV-1DVpu release in pri-
mary human target cells resulted in proinflammatory cytokine
release (Gala˜o et al., 2012). We therefore asked whether we
could detect tetherin phosphorylation in infected CD4+ T cells.
Purified and activated CD4+ T cells from two donors were in-
fected with HIV-1 (WT) or HIV-1DVpu at a multiplicity of infection
(moi) of 3 to ensure >90% infection. After 48 hr, viral release
was assessed, and as expected, infectious HIV-1DVpu release
was impaired (Figure 3A). In cells infected with HIV-1 (WT)
there was evidence of tetherin degradation (Figure 3C) and
reduced cell surface tetherin levels (not shown). This correlated
with enhanced mRNA expression of cxcl10, il6, and ifnb (Fig-
ure 3B). Tetherin could be precipitated with anti-pY antibody
from CD4+ T cells infected with HIV-1DVpu (Figure 3C), indi-
cating that physiological viral restriction induces its phosphory-
lation. Furthermore, supernatants derived from these cells
were used to treat human U87MG glioblastoma cells. U87MG
displays multiple blocks to HIV replication after exposure to
type 1 interferon (IFN) (Goujon et al., 2013). The cells were then
challenged with VSV-G pseudotyped HIV-1 to measure one-
round viral replication. Consistent with ifnb upregulation, treat-
ment of U87MG cells with supernatants from T cells infected
with the DVpu, but not WT, virus inhibited one-round HIV-1 repli-
cation by 8-fold (Figure 3D). Thus, not only does tetherin re-
striction of viral release promote proinflammatory responses in
primary CD4+ T cells, consistent with tetherin phosphorylation,
but these responses are sufficient to induce a robust antiviral
state in surrounding cells.
Tetherin Signaling and Phosphorylation Are Sensitive to
Inhibitors of Src-Family Kinases and Dependent on Syk
In order to show that tetherin phosphorylation is essential for vi-
rus-induced signaling, we first treated tetherin-transfected 293
cells (Figure S3A), or 293/tetherin-producing virus (Figure 4A)
with a broad-spectrum tyrosine kinase inhibitor Genistein. In
both cases, tetherin-dependent induction of the NF-kB reporter
gene was inhibited in a dose-dependent manner. In parallel
experiments, induction of an NF-kB signal through the overex-
pression of mitochondrial antiviral signaling protein (MAVS)
was unaffected (Figure S3A). Since the YDYCRV motif contains
a putative SH2-binding domain, we then assessed whether
tetherin-mediated signaling was sensitive to PP2, an inhibitor
of Src-family kinases that phosphorylate tyrosines in theseicrobe 16, 291–303, September 10, 2014 ª2014 The Authors 293
Figure 2. Retroviral Particle Retention Induces Tyrosine Phosphorylation of Human Tetherin
(A) Anti-pY immunoprecipitation of cell lysates from 293/tetherin cells transfected with wild-type and DVpu HIV-1 proviruses or MLV provirus and derivatives
(MLVDPY and MLVDPY/p6). Immunoprecipitates were deglycosylated, and tetherin was detected by western blot.
(B) Phosphorylated proteins were separated from lysates of 293/tetherin cells transfected with YFP control, DVpu HIV-1, or MLV proviruses using a Phospho-
protein Purification Column. Tetherin was detected by western blot of the flow-through or eluted fractions.
(C) 293/tetherin, single tyrosine (Y6A, Y8A), or double-tyrosine mutants (Y6,8A) assayed for the ability to induce NF-kB-luc reporter activation upon transfection
with MLV, MLVDPY, and MLVDPY/p6 (top). MLV infectivity was determined by titration of supernatants on 293T cells and analyzed by flow cytometry for GFP
expression 48 hr later (bottom). Error bars are ± SEM of three independent experiments.
(D and E) The same cells were transfectedwithMLV provirus or late domainmutantMLVDPY, and 24 hr later cells were lysed for immunoprecipitationwith anti-pY
(D) or anti-tetherin (E) antibodies. Precipitates were deglycosylated and analyzed by western blot as before. See also Figure S2.
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A Syk-Dependent HemITAM in Tetherinmotifs. Again, we observed dose-dependent inhibition of teth-
erin-dependent reporter gene activity from both overexpression
or cotransfection of MLV or HIV-1DVpu into 293/tetherin cells
(Figures S3B and 4B), while noting minimal effect on both virion
retention and viral assembly (Figures S3C and S3D). Importantly,
both Genistein (Figure S3E) and PP2 treatment also blocked the
ability to precipitate tetherin with anti-pY antibodies (Figures 4C
and S3F), indicating that tetherin phosphorylation is catalyzed by
Src-family kinases.
The similarities between the requirements for tetherin
signaling, and the hemITAMs found in dimeric C-type lectins
(Fuller et al., 2007; Sancho et al., 2009; Suzuki-Inoue et al.,
2006), prompted us to test whether this was also dependent
on Syk kinase binding to the tetherin phosphotyrosine motif.
We first depleted Syk using two siRNAs and found that both
significantly blocked NF-kB reporter gene activity from both
overexpressing tetherin and virion budding (Figures S3G and
4D). Again, while neither oligonucleotide had any effect on virion294 Cell Host & Microbe 16, 291–303, September 10, 2014 ª2014 Threlease or Vpu function (Figure S3H), Syk depletion specifically
blocked pull-down of phospho-tetherin (Figure 4E), suggesting
it either phosphorylates tetherin directly or stabilizes the phos-
phorylated form. Tetherin was then immunoprecipitated from
transiently transfected 293 cells (Figure S3I) or cells expressing
tyrosine mutant tetherins producing MLV VLPs to determine if
Syk associates with it (Figure 4F). In both cases Syk and its active
phosphorylated form (pSyk) could be detected in the presence of
WT tetherin, but not those bearing a Y6 mutation. Interestingly,
mutation of Y8 alone did not abolish Syk recruitment, but it
reduced the total amount detectable in the IP, consistent with
an intermediate signaling phenotype. We and others have previ-
ously found that the E3 ligases TRAF2 and TRAF6 and their
target kinase TAK1 associate with tetherin dependent on the
tyrosine motif (Gala˜o et al., 2012; Tokarev et al., 2013). Recovery
of phosphorylated proteins from 293/tetherin and 293/tetherin
Y6,8A cells producing MLV VLPs increased the yield of Syk,
TRAF2, TRAF6, and TAK1, but not TRAF3, consistent with thee Authors
Figure 3. Restriction of Tetherin-Sensitive HIV-1 Mutant Release from CD4+ T Cells Induces Tetherin Phosphorylation
(A) Purified CD4+ T cells from two donors were infected with HIV-1 wild-type orDVpu virus at anmoi of 3. At 48 hr later, infectious virus release was determined by
infection of HeLa-TZMbl reporter cell lines and western blot of cell lysates and supernatants for HIV-1 p24-CA.
(B) Total RNA from the cells infected in (A) was analyzed for cxcl10, il6, and ifnb mRNA levels relative to gapdh by qRT-PCR.
(C) Parallel CD4+ T cell cultures were infected as in (A). Cell lysates from these cultures were immunoprecipitated with an anti-pY antibody, deglycosylated, and
tetherin analyzed by western blot.
(D) U87MG cells were treated overnight with supernatants from CD4+ T cells infected as in (A) and then challenged with VSV-G pseudotyped HIV-1 WT virus
(moi of 0.5) in a one-round viral replication assay. Infectious virus release was determined 48 hr later as in (A).
Cell Host & Microbe
A Syk-Dependent HemITAM in Tetherinassembly of such a signaling complex (Figure 4G). Under the
same conditions, knockdown of Syk abolished the recovery of
all of these factors (Figure 4H), indicating that Syk recruitment
and tetherin phosphorylation are essential for the assembly of
the complex.
To confirm a role for Src family kinases and Syk in primary hu-
mancells,we thenassessed the sensitivity of tetherinphosphory-
lation to pharmacological inhibition in infected CD4+ T cells.
Under the conditions used in Figure 3, treatment with the Src
inhibitor PP2 or the Syk inhibitor Piceatannol abolished tetherin
phosphorylation and cytokine mRNA upregulation and their anti-
viral effects in cells infected with Vpu-defective HIV-1 without an
effect on viral release (Figures 4I, 4J, and S3J-S3L). T cells ex-
press a highly related kinase to Syk, Zap70, which has an essen-
tial role in T cell activation downstreamof ITAMmotifs in subunits
of the T cell receptor complex (Chu et al., 1998). In addition to
higher levels of phosphorylated Syk in HIV-1DVpu-infected cells,
we also found evidence of phospho-Zap70. Since Piceatannol
inhibits both kinases, we also used a Syk-selective inhibitor,
BAY61-3606. While this treatment effectively blocked the
appearance of phospho-Syk, BAY61-3606 markedly reduced,
but did not abolish, tetherin phosphorylation (Figure 4I). These
data therefore indicate that while Syk likely represents the major
effector of tetherin-mediated signal transduction in CD4+ T cells,
there may also be scope for some redundancy with Zap70.Cell Host & MSpecies Specificity of Tetherin Signaling Reflects
Efficiencies of Tyrosine Phosphorylation and Syk
Activation
The species specificity of tetherin signaling maps to its CT, as
well as a 2 amino acid insertion in the TM domain present in
humans and great apes (Figure S4A) (Gala˜o et al., 2012). The
former culminates in the enhanced activity of human tetherin
to activate NF-kB, while the latter suggests a conformational
change in the orientation of the CT between the tetherins of
hominoids and other primates. We therefore examined whether
different species of tetherins could be precipitated with anti-pY
antibodies upon overexpression. Consistent with their signaling
capabilities (Figure 5A), only the human and chimpanzee ortho-
logs could be precipitated in such a manner, with a trace
of gorilla tetherin detectable (Figure 5B). The species-specific
changes that we previously showed to impair tetherin signaling
(Gala˜o et al., 2012) (Figure S4A), as well as the Ser and Thr re-
sidues at positions 3 and 4 (Figure S4B), all impacted the effi-
ciency with which tetherin could be precipitated from transiently
transfected cells with anti-pY antibodies (Figure S4C). The
direct immunoprecipitation of primate tetherins revealed that
the nonsignaling tetherins reacted weakly with pY antibodies,
suggesting that they can be phosphorylated to some extent
(Figure 5C). However, while some Syk coprecipitated with
other primate tetherins, only phosphorylated Syk could beicrobe 16, 291–303, September 10, 2014 ª2014 The Authors 295
(legend on next page)
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Figure 5. Species Specificity of Tetherin’s Signaling Activity Is Linked to Syk Recruitment and Tyrosine Phosphorylation
(A) NF-kB-luc reporter activation in 293 cells transfected with increasing amounts of human, chimpanzee, gorilla, AGM, and rhesus tetherins. Alignment of
cytoplasmic tails of primate tetherins is presented in Figure S4A. Error bars represent ± SEM of three experiments.
(B) Anti-pY immunoprecipitation of lysates from the 50 ng input of (A) deglycosylated and western blotted for tetherin.
(C) As in (B), but cell lysates were precipitated with anti-tetherin antibodies, and precipitates were analyzed for phosphorylated tetherin (anti-pY), Syk, or pSyk.
See also Figure S4.
Cell Host & Microbe
A Syk-Dependent HemITAM in Tetherindetected in association with the human and chimpanzee pro-
teins (Figure 5C).
Tetherin-Mediated Virion Retention and Signal
Transduction Are Coupled via the Actin Cytoskeleton
and RICH2
Our previous observations and those herein provide evidence for
the dual nature of the YDYCRV in tetherin, depending on its pres-
ence in long tetherin homodimers. In particular, our previous
data indicated that blockade of tethered virion endocytosis
potentiates signaling, suggesting that the clustering of tetherin
dimers at the plasma membrant (PM) in assembling virions is
the primary trigger (Gala˜o et al., 2012). Interestingly, there is
evidence that hemITAM function in C-type lectins requires the
underlying actin cytoskeleton (Pollitt et al., 2010). Since tetherin
has been previously associated with the cortical actin network
(Rollason et al., 2009), we tested whether tetherin signaling
upon virion retention was sensitive to actin depolymerization.
Treatment of 293/tetherin cells transfected with Vpu-defectiveFigure 4. Tetherin Phosphorylation Is Sensitive to Inhibitors of Src-Fam
(A and B) Fold activation of NF-kB-luc reporter in 293/tetherin cells transfected w
inhibitors Genistein (A) or PP2 (B). NF-kB fold changes relative to cells transfecte
(C) Immunoprecipitation of cell lysates from (B) with an anti-pY antibody. Precipita
and analyzed as previously described.
(D) 293/tetherin cells were transfected twice over 72 hr with siRNAs directed again
transfected with the NF-kB reporter plasmid and the indicated viral plasmid. Fold
bars represent ± SEM of three experiments. *p > 0.05, **p > 0.01, and ***p > 0.0
(E) Western blots of anti-pY immunoprecipitates from (D).
(F) Lysates of 293 stably expressing wild-type tetherin or tyrosine mutants transf
Pull-downs were analyzed by western blot for tetherin, pY, Syk, and its active ph
(G and H) Phosphorylated proteins were separated fromMLV-transfected lysates
by siRNA (H),using a Phosphoprotein Purification Column. Eluate fractions were
(I) Purified CD4+ T cells were infected with HIV-1 WT or DVpu viruses (moi of 3) in
BAY61-3606 (2.5 mM). At 48 hr after infection, cell lysates were immunoprecipitate
by western blot for tetherin, pSyk, and pZAP70.
(J) Cxcl10, il6, and ifnb mRNA levels in parallel cultures infected and treated as i
Cell Host & MHIV-1 or MLV VLPs with cytochalasin D completely abolished
the activation of the NF-kB reporter construct without affecting
this response induced by MAVS overexpression (Figure 6A). By
contrast, neither viral infectivity, tetherin surface expression,
nor tetherin-mediated restriction of viral release were affected
by this treatment (Figures 6B and S5A). Furthermore, in parallel
experiments, cytochalasin D also blocked the ability to
precipitate phosphorylated tetherin in MLV-transfected cells
and prevented coimmunoprecipitation of phosphorylated Syk
(Figure 6C). Mature tetherin localizes to detergent-resistant
microdomains (DRMs) by virtue of its GPI anchor (Kupzig et al.,
2003). Neither MLV proviral expression nor cytochalasin D treat-
ment had any effect on the partitioning of tetherin into DRMs
isolated on OptiPrep gradients (fraction 3, Figure S5B). Interest-
ingly, phospho-tetherin and Syk could be immunoprecipitated
only from the DRM fraction in the presence ofMLV VLP assembly
(Figure S5C), suggesting that tetherin-mediated virion retention
is sensed through the actin cytoskeleton and is dependent on
its spatial distribution at the PM.ily Kinases and Requires the Recruitment of Syk
ith HIV-1 DVpu or MLV proviruses in the presence of increasing amounts of the
d with control YFP and not treated with inhibitors.
tes from 293/tetherin cells transfected with MLV provirus were deglycosylated
st Syk (siSyk_1 and _2) or a nontargeting control (siNeg). 293 tetherin cells were
increases in luciferase expression are plotted relative to YFP control. All error
01 as determined by paired two-tailed t test.
ected with MLV provirus were immunoprecipitated with anti-tetherin antibody.
osphorylated form (pSyk).
of 293/tetherin and 293/tetherin-Y6,8A (G) or 293/tetherin cells depleted of Syk
analyzed by western blot for the indicated protein.
the presence or absence of the inhibitors PP2 (20 mM), Piceatannol (10 mM), or
d with an anti-pY antibody, and pull-downs were deglycosylated and analyzed
n (I). Data are represented as ± SEM. See also Figure S3.
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Figure 6. Tetherin-Mediated Signaling Is Impaired by Cytochalasin D Treatment and RICH2 Depletion
(A) Fold activation of NF-kB-luc reporter in 293/tetherin cells transfectedwithMLV provirus, wild-type,DVpuHIV-1 proviruses, orMAVS and treated for 6–8 hr with
increasing amounts of the actin polymerization inhibitor cytochalasin D.
(B) HIV-1 infectious viral particle release from supernatants in (A) was determined on HeLa-TZM cells.
(C) 293/tetherin cells were transfected with MLV provirus in the presence of increasing amounts of cytochalasin D inhibitor. Lysates were immunoprecipitated
with an anti-tetherin antibody and analyzed by western blot for anti-pY, Syk, and pSyk.
(D) NF-kB reporter activation in RICH2 siRNA-depleted 293/tetherin cells transfected with wild-type HIV-1, DVpu HIV-1, or MLV proviruses. Knockdown of
RICH2 was confirmed by western blot (inset). Error bars represent ± SEM of three experiments. *p > 0.05, **p > 0.01, and ***p > 0.001 as determined by paired
two-tailed t test.
(E and F) Infectious HIV release (E) and precipitation of phospho-tetherin by anti pY fromMLV transfected cells (F) were analyzed as in previous figures. See also
Figure S5.
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tified to link tetherin to the cortical actin network in polarized cells
(Rollason et al., 2009). We hypothesized that RICH2 might play a
role in the initiation of tetherin-mediated signal transduction.
Depletion of RICH2 in 293/tetherin cells by RNAi specifically
blocked the ability of both HIV-1DVpu and MLV to induce NF-
kB-luciferase (NF-kB-luc) reporter gene activity (Figure 6D) but
had no effect on the release of either HIV-1DVpu (Figure 6E) or
MLV (not shown), indicating that it plays no direct role in tethe-
rin’s physical antiviral function but is required for the initiation
of signaling. In keeping with this, RICH2 RNAi blocked detection
of phosphorylated tetherin under these conditions (Figure 6F).
We then examined RICH2 interaction with tetherin. An
N-terminally hemagglutinin (HA)-tagged human RICH2 copreci-
pitated with human, ape, and rhesus macaque, but not African
green monkey (AGM), tetherins (Figure 7A), indicating the deter-
minants of interaction are at least partially conserved and do not
correlate with signaling capacity. The juxtamembrane region of
the CT of tetherin is more conserved in primates (Figure S4A),298 Cell Host & Microbe 16, 291–303, September 10, 2014 ª2014 Thand most mutations in this region of human tetherin have little
effect on signaling. However, rhesus and AGM tetherins differ
at two positions (21 and 24). Interestingly, a recent study has
documented a rare polymorphism in the human tetherin CT,
R19H (Sauter et al., 2013). The R at the equivalent position (24)
is shared in rhesus, but not AGM, tetherin. In the context of the
human protein, the R19H polymorphism reduced efficiency of
NF-kB activation without affecting antiviral activity (Sauter
et al., 2013). In agreement with these data, we found that
NF-kB activation by tetherin-R19H was reduced 5- to 6-fold
compared to the wild-type protein when overexpressed by tran-
sient transfection (Figure S6A). When the protein was stably ex-
pressed in 293 cells, HIVDVpu virion retention by tetherin R19H
failed tomediate NF-kBactivation (Figures 7B andS6B). Further-
more, no evidence of tetherin phosphorylation was observed in
293/tetherin-R19H cells producing MLV VLPs (Figure 7C). Inter-
estingly, tetherin R19H displayed a marked reduction in the abil-
ity to coprecipitate HA-tagged RICH2 (Figure 7D), suggesting
that a defect in this interaction underlies the signaling impairmente Authors
Figure 7. RICH2/Tetherin Interactions Are Required for Virion-Induced Signaling
(A) 293 cells were cotransfected with an N-terminally HA-tagged human RICH2 and tetherin from humans, chimpanzee, gorilla, rhesus, or AGM. Lysates were
immunoprecipitated with an anti-tetherin antibody, and precipitates were blotted for HA and tetherin.
(B) Fold activation of a NF-kB-luc reporter in 293 cells expressing tetherin, or the mutants Y6,8A and R19H, transfected with HIV-1WT orDVpu proviruses relative
to YFP control. Error bars represent ± SEM of three experiments.
(C) The above stable cells lines were transfected with MLV provirus and lysed 24 hr later for immunoprecipitation with a anti-pY (left) or anti-tetherin (right)
antibodies. Precipitates were deglycosylated and analyzed by western blot as before.
(D) 293 cells were cotransfected with HA-RICH2 and wild-type tetherin or the mutants Y6,8A, Y6A, Y8A, or R19H. Lysates were immunoprecipitated with an anti-
tetherin antibody and analyzed as in (A).
(E) Model for Syk-dependent tetherin-mediated signaling as discussed in the Discussion. See also Figure S6.
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polymorphism also displayed only weak dominant interfering ac-
tivity (Figure S6C), in agreement with the previous study (Sauter
et al., 2013). Together, these data indicate that RICH2/tetherin
interactions are important to trigger the cytoskeletal-dependent
activation of tetherin signaling downstream of virion retention.
Furthermore, this interaction is defined in part by a juxtamem-
brane determinant in the tetherin CT that defines a rare signaling
polymorphism in humans.
DISCUSSION
In this study we have probed the mechanism by which restric-
tion of viral release by human tetherin triggers proinflamma-
tory signaling (Figure 7E). We find results consistent with the
YDYCRV motif in tetherin acting like hemITAMs found in several
dimeric C-type lectins. Retroviral assembly and release isCell Host & M‘‘sensed’’ through tetherin’s link to the cortical actin network
via RICH2, which leads to tyrosine phosphorylation of tetherin
by Src-family kinases and recruitment of Syk. This in turn pro-
motes NF-kB activation dependent on TRAFs 2 and 6 and
TAK1, as we and others have previously shown (Gala˜o et al.,
2012; Tokarev et al., 2013). Together, these data provide a plau-
sible model for how an infected cell can detect the illicit budding
of enveloped virions at plasma membrane through the antiviral
activity of tetherin. Furthermore, the species specificity of this
mechanism suggests that changes in the tetherin CT and its
orientation during hominid evolution permitted the dual-tyrosine
traffickingmotif to be phosphorylated and act as an SH2-binding
site for Syk.
This mechanism of hemITAM signaling in tetherin is very
similar to that described for the C-type lectins CLEC2, Dectin-
1, and DNGR-1 (Fuller et al., 2007; Sancho et al., 2009; Suzuki-
Inoue et al., 2006). In all cases, these are type II membraneicrobe 16, 291–303, September 10, 2014 ª2014 The Authors 299
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dimerize upon ligand binding. CLEC2 binding of its ligand, rho-
docytin, leads to its translocation to lipid rafts and phosphoryla-
tion by Src in an actin-dependent manner (Pollitt et al., 2010).
This recruits Syk to the phosphorylated YXXL SH2-binding site
(Se´verin et al., 2011). Tetherin constitutively resides in choles-
terol-rich microdomains by virtue of its GPI anchor (an essential
attribute for signaling) (Kupzig et al., 2003). We propose that sur-
face clustering of tetherin by virus budding is sensed similarly
through the actin cytoskeleton. In contrast to other hemITAMs,
tetherin bears an unusual dual-tyrosine motif, of which Y6 is
essential. Surprisingly, mutation of Y8, which is in the context
of a canonical SH2-binding domain, affects the efficiency of
signaling and Syk recruitment but does not abolish it. Further-
more, a Y8H polymorphism that maintains signaling and antiviral
activity in transient assays has been detected in humans (Sauter
et al., 2013). Since phosphorylation of either tyrosine has
been detected in phosphoproteome studies (St-Germain et al.,
2009), a potential explanation might be that initial Y6 phosphory-
lation by Src-family kinases (or Syk itself) leads to recruitment of
Syk, which then phosphorylates Y8 to stabilize the interaction.
How the TRAF2/TRAF6/TAK1 complex is recruited remains to
be determined. If tetherin signaling is similar to other hemITAMs,
then the route to NF-kB may be through phospholipase C, PKC,
and the CARD9/Bcl10/MALT1 complex (Strasser et al., 2012).
Whether tetherin-mediated restriction modulates other pattern
recognition pathways through Syk is another interesting ques-
tion. Dectin-1 ligation leads to inflammasome activation through
Syk in combination with Toll-like receptor 2 (TLR2) (Hise et al.,
2009), and we have previously shown that tetherin-dependent
type 1 IFN production in T cells may also require a TLR/TRIF
pathway (Gala˜o et al., 2012). Furthermore, tetherin has been pro-
posed as a cofactor for the leukocyte inhibitory receptor ILT-7,
which suppresses TLR responses in plasmacytoid dendritic cells
(pDCs) in combination with FcεRIg (Cao et al., 2009). While these
observations are controversial (Tavano et al., 2013), they high-
light scope for tetherin signaling to impact upon the regulation
of other innate immune responses.
The implication of RICH2 in the mechanism of tetherin
signaling is intriguing. RICH2, a BAR-domain containing
RacGAP was identified several years ago as linking tetherin to
the subapical cortical actin in polarized epithelial cells via ezrin
and EBP50 (Rollason et al., 2009). This interaction was required
for the maintenance of the cortical actin network, and its
disruption led to the activation of the GTPase Rac. While such
a phenotype may not be consistent with the apparently normal
development of tetherin knockout mice (Liberatore and Bieniasz,
2011), these data suggest that actin dynamics may play a role in
tetherin’s activity in vivo. Our data indicate that RICH2 and the
cortical actin are not required for restriction of virion release,
consistent with tetherin’s proposed mechanism of virion entrap-
ment (Venkatesh and Bieniasz, 2013). However, coupling tethe-
rin to actin via RICH2 provides a plausible explanation for our
previous observations that tetherin clustering by crosslinking
or virion budding is the primary trigger of signal transduction
(Gala˜o et al., 2012) and suggests a mechanism through which
Src-family kinases can be activated. RICH2 is unlikely to simply
be required for tetherin-dependent signaling. Human RICH2 was
initially isolated from cell lysates using the rat tetherin CT as bait,300 Cell Host & Microbe 16, 291–303, September 10, 2014 ª2014 Thsuggesting cross-species conservation of such an interaction
(Rollason et al., 2009). Data herein indicate that human RICH2 in-
teracts with a subset of signaling and nonsignaling primate teth-
erins. Although the molecular determinants are yet to be fully
described, RICH2 interactions with human tetherin are affected
by a rare natural polymorphism previously found to be defective
for signal transduction (R19H). The equivalent position varies be-
tween rhesus and AGM tetherins, which differ in human RICH2
interactions despite both being unable to signal in human cells.
The RICH2-mediated linkage to actin may also be required for
the internalization of tethered virions for endosomal degradation.
This internalization would also likely require actin dynamics,
and hence a coupling to Rho-family GTPases, whose role in
both tetherin signaling and virion internalization remains to be
determined. Interestingly, a rare synonymous polymorphism in
RICH2 adjacent to the splice acceptor in exon 11 has been asso-
ciated with slow progression to AIDS (Le Clerc et al., 2011),
raising a possibility that the R19H tetherin polymorphism or dif-
ferential expression of splice variants of RICH2 may affect tethe-
rin’s function in vivo.
Our data have shed further light on the species specificity of
tetherin signaling, particularly as the virtual invariance of the
Syk and RICH2 sequences in primates argues against either
determining the lack of signaling activity in monkey tetherins.
Changes in the tetherin CT and a 2 amino acid TM insertion
that occurred during hominoid evolution have generated a
signaling capacity coupled to its antiviral action (Gala˜o et al.,
2012). This correlates with tetherin phosphorylation and Syk acti-
vation. We suggest that a potential conformational change in the
CT produced by the lengthening of TM domain changed the
position of the tyrosine residues such that Y6 was amenable to
phosphorylation. Importantly this was accompanied by KM-to-
RV changes adjacent to Y8 as well as residues upstream of Y6
that facilitated interaction with Syk to create a noncanonical
hemITAM. Finally, the 5 amino acid indel that occurred after
hominids and chimpanzees diverged (Sauter et al., 2011)
enhanced this signaling capacity (Gala˜o et al., 2012). Since
some of these differences encompass residues that have been
identified as modulating sensitivity to lentiviral Nefs (the indel)
and Vpus (the TM insertion) (reviewed in Neil, 2013), we specu-
late that at least some of these changes may have resulted
from pathogen counteraction of tetherin’s antiviral activity. How-
ever, the dual-tyrosine motif is present in the long isoforms of the
majority of mammalian tetherins, irrespective of signaling activ-
ity. This motif is required for tetherin recycling via the trans-Golgi
network (TGN) and has been shown to bind to both AP1 and AP2
(Rollason et al., 2007). By contrast, tetherin-retained virions are
internalized and targeted to late endosomes (Neil et al., 2008),
suggesting that the act of viral restriction modulates tetherin traf-
ficking. Since most mammalian tetherins do not signal, why are
the two isoforms (with and without the dual tyrosines; Cocka
and Bates, 2012) maintained? A possibility is that a dual motif
in both long-tetherin homodimers and mixed heterodimers acts
as the switch that targets virions for degradation, whereas stabi-
lization of the short isoform at the surface could enhance opso-
nization. Indeed, endosomal virion localization is reduced when
the tyrosines aremutated (Gala˜o et al., 2012). In addition to virion
degradation, it may afford certain cell types the ability to turn viral
antigens over for presentation or expose virion components toe Authors
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2012). Coupling the phosphorylation to downstream internaliza-
tion may also be important for damping down tetherin signaling
by targeting activated molecules for endosomal degradation.
Such a preexisting function of the tyrosine motif is an attractive
starting point from which to evolve a further function, namely
proinflammatory signaling coupled to tetherin’s antiviral activity.
It also raises questions of whether tetherin function is compro-
mised in mammals that lack expression of the long isoform
entirely, as suggested by the recent studies showing that
expression of both isoforms qualitatively influences innate and
adaptive immune responses to MLV infection in mice (Li et al.,
2014).
The long isoform of human tetherin is more efficiently targeted
by M group HIV-1 Vpu because, in contrast to the short form, it
can induce its degradation (Cocka and Bates, 2012; Weinelt
and Neil, 2014). This differential sensitivity and targeted degra-
dation is not observed in lentiviral countermeasures from viruses
that infect primate species whose tetherins lack NF-kB activa-
tion (Weinelt and Neil, 2014). Furthermore, the acquisition of
long tetherin isoform degradation in only HIV-1 group M tempts
speculation that tetherin’s signaling capacity had a major effect




Human and primate tetherin constructs, or mutants thereof, were made by
standard techniques in pCR3.1 (Invitrogen) or pLHCX (Clontech). Tetherin-ex-
pressing 293 cells were generated by retroviral vector transduction of pLHCX
constructs followed by hygromycin selection. HIV-1 and MLV proviral/vector
plasmids and firefly luciferase NF-kB and Renilla control reporter plasmids
were described previously (Gala˜o et al., 2012) and detailed in the Supple-
mental Experimental Procedures. A codon-optimized human RICH2 was
synthesized (MWG) and cloned into pCR3.1 with an N-terminal HA tag.
CD4+ T cells were isolated from healthy donors using an Untouched CD4+
T cell Dynabead kit (Life Technologies), activated for 48 hr prior to infection
with anti-CD3/CD28 dynabeads (Life Technologies), and cultured in 30 U/ml
human IL-2.
Reporter Gene Assays
Reporter gene assays in 293 cells transiently transfected with tetherin expres-
sion vectors were performed as described previously (Gala˜o et al., 2012) using
a Promega Dual luciferase kit. For viral-mediated reporter gene assays, 293
cells or 293 cells stably expressing tetherin were transfected with 10 ng of
3xkB-pCONA-FLuc and of pCMV-RLuc in combination with 600 ng of HIV or
MLV proviruses. For experiments with MLV or derivatives, 200 ng of the
MLV GFP-encoding vector, pCNCG, and 100 ng of pVSV-G were cotrans-
fected to allow infectious release to be measured (see below).
For reporter gene assays in the presence of inhibitors, cells were transfected
as described above. At 4 hr posttransfection, cells were treated for 6–8 hr with
increasing amounts of the inhibitors Genistein (Source Bioscience), PP2
(Sigma), or cytochalasin D (Sigma), after which fresh medium was added.
Tetherin expression on the cell surface was determined by flow cytometry
using anti-human BST2-PE (eBiosciences). The irreversible Syk inhibitors
Piceatannol (Invivogen) and BAY61-3606 (Sigma) were used to treat infected
primary T cells for 8 hr, and cells were harvested 24 hr later.
For RNAi knockdown of Syk and RICH2, 23 105 cells were seeded per well
of a 12-well plate and transfected 6 hr later with 100 pmol of siRNA in complex
with Dharmafect-1 (Dharmacon). At 48 hr later, cells were reseeded and
cotransfected with a second dose of siRNA alongside reporter constructs
as per the transient reporter gene assays. The following siRNAs were
used: Hs_SYK_6 and Hs_SYK_8 (QIAGEN: SI02223151 and SI02655135),Cell Host & MsiNegative control siRNA duplex (1027310), and Thermo Scientific ON-
TARGETplus SMARTpool for human ARHGAP44 (RICH2) (L-009238-01). Pro-
tein knockdowns were verified by western blot with antibodies detailed in the
Supplemental Experimental Procedures.
Virus Stocks, Primary Cell Infections, and Release Assays
HIV-1 NL4.3 wild-type and DVpu viral stocks were produced in 293T cells by
transient transfection. Viral stocks were treated for 2 hr with 10 U/ml DNase-
I (Roche) and 10 mM MgCl2 and then concentrated by ultracentrifugation
through a 20% sucrose/PBS cushion (30,000 rpm on a SuperSpin 360 rotor
for 90 min) and resuspended in RPMI. Endpoint titers were determined on
the HeLa-TZM reporter cell line as described previously (Gala˜o et al., 2012).
For viral release assays in primary HIV target cells, 5 3 105 activated CD4+
T cells were infected at an moi of 3 to ensure >90% p24+ cells 48 hr postin-
fection. HIV-1 infection of T cells was monitored by flow cytometry using
intracellular anti-p24-PE staining (Beckman Coulter). The infectivity of viral
supernatants was determined on HeLa TZM cells, while HIV-1 particle release
was determined by western blot as previously described (Gala˜o et al., 2012).
Cells were also harvested for immunoprecipitation studies, and total RNA
was isolated, reverse transcribed, and resultant cDNA was used for quantita-
tive RT-PCR to determine relative mRNA expression levels of cxcl10, il6,
and ifnb relative to gapdh by qRT-PCR using TaqMan assay (ABI) primer
probes. MLV vector titers were determined by transducing 293T cells and
enumerating the GFP-positive cells by fluorescence-activated cell sorting
48 hr later.
Antiviral Activities of ConditionedMedia from Infected CD4+ T Cells
To assess the antiviral activity of supernatants from HIV-1-infected CD4+
T cells, 105 U87MG glioblastoma cells, which are devoid of HIV receptor
expression and therefore cannot be infected by virus released into the T cell
supernatant, were treated with 200 ml of conditioned medium for 24 hr. The
cells were then challenged with VSV-G pseudotyped WT HIV-1 at an moi of
0.5. The medium was changed 6 hr later, and 48 hr postinfection, infectivity
in the medium was assessed on HeLa-TZM indicator cells as a measure of
one-round virus replication.
Immunoprecipitations and Purification of Phosphorylated Proteins
For transient assays, 293 cells were transfected with 500 ng of pCR3.1-YFP or
pCR3.1 tetherin constructs using Lipofectamine. For viral-based assays,
10 cm dishes of 293 cells stably expressing different tetherins were trans-
fected with 6 mg of HIV or MLV proviruses. At 24 hr posttransfection, cells
were lysed with a buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, 200 mM sodium orthova-
nadate, and protease inhibitors (Roche). Following sonication, lysates were
immunoprecipitated with either mouse anti-phosphotyrosine (clone 4G10)
(Millipore) or rabbit anti-BST2 polyclonal (kindly provided by K. Strebel through
the NIH ARPP; Miyagi et al., 2009) antibodies and protein G agarose beads
(Life Technologies) for 3 hr. Proteins bound to the beads were then deglycosy-
lated by an overnight treatment with PNGase F (NEB).
For the separation of phosphorylated and unphosphorylated proteins from
cell lysates, a PhosphoproteinProtein Purification kit (QIAGEN) was used,
following the manufacturer’s instructions. Total eluates were concentrated us-
ing Nanosep Ultrafiltration Columns (QIAGEN) down to a final volume of 50 ml.
Cell lysates, IPs, and eluates were subjected to SDS-PAGE and western
blots performed using antibodies against BST2, pY, and cellular factors
detailed in the Supplemental Experimental Procedures. Blots were visualized
by ImageQuant using anti-mouse or anti-rabbit HRP-linked antibodies (NEB)
or an anti-goat HRP-linked antibody (Santa Cruz Biotechnology).
Statistical Analysis
Statistical significance was determined using paired two-tailed t tests calcu-
lated using the Prism software. Significance was ascribed to p values as fol-
lows: *p > 0.05, **p > 0.01, and ***p > 0.001.
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